Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,001-3,012 of 4,306
Drug study icon
CompletedNCT03485417

Substance Misuse To Psychosis for Stimulants

This summary needs review. Please check the official study record and contact the research team for details.

In Hong Kong
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 16 Years to 50 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02404194

Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 30 Years
Countries
United States
Sponsor
Rush University Medical Center
Condition
Schizophrenia
Other study type icon
CompletedNCT03178279

The Evaluation of the Use of a New Physical Health Plan

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Other study type icon
TerminatedNCT03152292

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cullman
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT03340909

The Norwegian Prednisolone in Early Psychosis Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bergen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
Schizophrenia
Other study type icon
CompletedNCT04444180

The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 11 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Drug study icon
WithdrawnNCT01724372

The Role of Antidepressants or Antipsychotics in Preventing Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 12 Years to 25 Years
Countries
Sponsor
St. Luke's-Roosevelt Hospital Center
Condition
Schizophrenia
Other study type icon
WithdrawnNCT04369677

Thermoregulation Among Individuals With First-episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Columbus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 35 Years
Countries
United States
Sponsor
Nicholas Breitborde
Condition
Schizophrenia
Drug study icon
TerminatedNCT00160147

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 65 Years to 90 Years
Countries
United States, Czechia, Estonia, ...
Sponsor
Solvay Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.